United States Pharmaceuticals

Medimmune LLC (MEDI)

Track

Ticker: MEDI Exchange: NSQ
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Sale 13 Feb 2007
Value US$3,391,335.45 | Price 340.85 | Shares 86,795 (+11.6%)
Sale 13 Feb 2007
Value US$4,521,722.79 | Price 75.28 | Shares 47,291 (+14.1%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2007-02-15 2007-02-13 S Sale ZOTH LOTA S

Senior Vice President & CFO

Officer
86,795 +11.6%
340.85
US$3,391,335 		86,795 +11.6% 340.85 US$3,391,335
2007-02-15 2007-02-13 S Sale ZOTH LOTA S

Senior Vice President & CFO

Officer
47,291 +14.1%
75.28
US$4,521,723 		47,291 +14.1% 75.28 US$4,521,723
2007-02-12 2007-02-08 S Sale CONNOR EDWARD M

Executive Vice President, CMO

Officer
37,570 +42.1%
289.33
US$717,866 		37,570 +42.1% 289.33 US$717,866
2006-02-09 2006-02-08 S Sale Kiener Peter A

SVP, Research

Officer
12,000 -100.0%
33.41
US$400,955 		12,000 -100.0% 33.41 US$400,955
2006-02-09 2006-02-07 S Sale HACKMAN FRANKLIN BARBARA Non-Executive Director
40,000 -89.0%
33.68
US$1,347,052 		40,000 -89.0% 33.68 US$1,347,052
2006-02-07 2006-02-03 S Sale Mathers Edward T

SVP, Corporate Dev.

Officer
40,000 -100.0%
32.59
US$1,303,420 		40,000 -100.0% 32.59 US$1,303,420
2006-02-07 2006-02-03 S Sale ANIDO ARMANDO

EVP, Sales and Mktg

Officer
7,187 -83.0%
32.75
US$235,374 		7,187 -83.0% 32.75 US$235,374
2006-02-07 2006-02-03 S Sale ANIDO ARMANDO

EVP, Sales and Mktg

Officer
4,375 -33.6%
32.60
US$142,625 		4,375 -33.6% 32.60 US$142,625
2006-02-07 2006-02-03 S Sale YOUNG JAMES F

President, R&D

Officer
8,640 -50.0%
32.62
US$281,864 		8,640 -50.0% 32.62 US$281,864
2005-11-16 2005-11-14 S Sale Folena-Wasserman Gail M

SVP, Development

Officer
42,000 -100.0%
35.36
US$1,485,162 		42,000 -100.0% 35.36 US$1,485,162
2005-11-09 2005-11-08 S Sale ANIDO ARMANDO

EVP, Sales & Marketing

Officer
40,625 -96.5%
34.90
US$1,417,837 		40,625 -96.5% 34.90 US$1,417,837
2005-10-25 2005-10-21 S Sale Machielse Bernardus N M

SVP, Operations

Officer
2,000 -34.4%
34.11
US$68,216 		2,000 -34.4% 34.11 US$68,216
2005-10-25 2005-10-21 S Sale Machielse Bernardus N M

SVP, Operations

Officer
70,000 -92.3%
33.41
US$2,339,036 		70,000 -92.3% 33.41 US$2,339,036
2005-03-04 2005-03-03 S Sale MACKLIN GORDON S Non-Executive Director
30,000 -75.0%
24.17
US$725,076 		30,000 -75.0% 24.17 US$725,076
2005-02-08 2005-02-07 PlS Planned sale CONNOR EDWARD M

EVP and Chief Medical Officer

Officer
100,000 -100.0%
24.31
US$2,431,290 		100,000 -100.0% 24.31 US$2,431,290
2004-08-03 2004-07-30 S Sale HACKMAN FRANKLIN BARBARA Non-Executive Director
40,000 -89.0%
23.07
US$922,836 		40,000 -89.0% 23.07 US$922,836
2004-05-06 2004-05-06 S Sale
MACKLIN GORDON S
105,000 -91.3%
24.26
US$2,547,436 		105,000 -91.3% 24.26 US$2,547,436
2004-04-30 2004-04-28 S Sale BOOTH MELVIN D Non-Executive Director
431,820 -99.5%
25.71
US$11,101,401 		431,820 -99.5% 25.71 US$11,101,401
2004-04-30 2004-04-28 S Sale BOOTH MELVIN D Non-Executive Director
18,180 -89.7%
25.60
US$465,408 		18,180 -89.7% 25.60 US$465,408
2004-02-06 2004-02-05 PlS Planned sale CONNOR EDWARD M

SVP Clinical Development
69,996 -100.0%
24.59
US$1,721,293 		69,996 -100.0% 24.59 US$1,721,293
Explore more

More insider trading research around Medimmune LLC

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America